CoChat

Multimodal neuroimaging and AI integration in cognitive disorders: advances, challenges, and future directions for precision medicine

Open access
Dang, Mingxi, Liu, Bing, Chen, Yaojing, Zhang, Zhanjun · 2026 · Psychoradiology

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index; 110 of the 167 sources its claims cite were checked for support.

Abstract

Cognitive disorders, with dementia as a primary exemplar, present profound diagnostic and therapeutic challenges due to their complex pathologies and heterogeneous presentations. Artificial intelligence (AI), particularly when applied to multimodal neuroimaging and clinical data, offers a powerful approach to advancing precision medicine in this domain. This comprehensive review first examines foundational AI algorithms, including artificial neural networks for feature extraction, multimodal fusion strategies (e.g. early, intermediate, and late fusion) for data integration, and explainable AI (XAI) techniques to enhance clinical transparency. The core focus is on the application of these multimodal AI frameworks across the dementia care continuum, encompassing improved differential diagnosis, early detection through presymptomatic biomarkers, development of predictive models for disease progression, and optimization of patient stratification for clinical trials. Despite significant advances, persistent challenges remain, including limited generalizability across populations and protocols, data scarcity for non-Alzheimer’s dementias and prodromal stages—exacerbated by demographic biases—and barriers to interpretability. We discuss solutions such as federated learning for privacy-preserving data sharing and advanced XAI techniques. Finally, we outline pivotal future directions, including intelligent sensor fusion for discovering novel early biomarkers, hybrid AI architectures combining generative and discriminative models, innovations for handling missing modalities, and robust multicenter data integration frameworks. By synthesizing these advances, this review highlights the role of multimodal AI in advancing precise diagnosis, early prediction, and therapeutic development for neurodegenerative and vascular cognitive disorders, while identifying key translational challenges for precision medicine.

Overview

CoChat Summary

TL;DR

This comprehensive review synthesizes AI algorithms and multimodal neuroimaging frameworks for cognitive disorders, spanning differential diagnosis, early detection, progression prediction, and clinical trial stratification. It highlights substantial advances alongside persistent challenges in generalizability, data scarcity and demographic bias, and interpretability, and outlines solutions such as federated learning, explainable AI, and missing-modality fusion.

Key findings

  • Multimodal integration generally outperforms unimodal approaches: combining MRI, FDG-PET, and CSF yielded 5–10% accuracy gains over MRI alone (Kohannim et al., 2010), while Aβ-PET/tau-PET/FDG-PET individually achieved 81%/85%/88% accuracy versus 95% when all three were integrated (Dang et al., 2023).
  • AI supports differential diagnosis and early detection: MC-004 EEG discriminated DLB from AD with 72.2% sensitivity, 85.7% specificity, and 79.5% accuracy; an FDG-PET deep learning model predicted AD diagnosis 6.3 years before clinical manifestation with 82% specificity and 100% sensitivity; a 10-etiology multimodal model achieved AUC 0.94 for NC/MCI/dementia discrimination and AUC 0.96 for etiology differentiation (Xue et al., 2024).
  • Progression prediction and stratification show moderate to strong performance: MCI-to-AD conversion models typically peak at AUC 0.80–0.85; hippocampal covariance network signatures improved early MCI prediction from AUC 0.72 to 0.79 with 86% sensitivity; and an AI model recommending cognitive-enhancing therapy was associated with a 0.60-point MMSE reduction versus 2.80 points in nonadherent patients.
  • Key challenges include generalization failure—neuroimaging classifiers dropped from 73% accuracy within training hospitals to 55% at unseen sites—and data scarcity/demographic underrepresentation; federated learning raised balanced accuracy from 0.51 to 0.80 for smaller speech-based datasets, while XAI methods such as Grad-CAM and SHAP and intermediate fusion are proposed to improve trust and handle missing modalities.

Methods

  • Design: comprehensive review of AI algorithms and multimodal neuroimaging frameworks applied to cognitive disorders, including dementia as the primary exemplar.
  • Data or sample: no new primary cohort; the paper synthesizes published studies, tables, and cited literature across differential diagnosis, early detection, progression prediction, and patient stratification.
  • Main analysis: narrative synthesis of artificial neural networks, CNNs, GCNs, GANs, multimodal fusion strategies (early, intermediate, late), explainable AI techniques, clinical applications, challenges, and future directions.

Limitations

  • The paper does not state limitations of its own review methodology.
  • Evident from the text: as a comprehensive review, it does not report a systematic search strategy, inclusion criteria, or quantitative meta-analysis, so its conclusions depend on the cited literature and may be subject to selection or synthesis bias.
  • The review itself notes field-level limitations: limited generalizability across populations and protocols, data scarcity for non-Alzheimer’s dementias and prodromal stages, demographic biases, and barriers to interpretability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/psyrad/kkag007

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1: AI frameworks for neuroimaging in cognitive disorders research: key algorithms and strategies. AD, Alzheimer’s disease; PD, Parkinson’s disease; VaD, vascular dementia.
Figure 1: AI frameworks for neuroimaging in cognitive disorders research: key algorithms and strategies. AD, Alzheimer’s disease; PD, Parkinson’s disease; VaD, vascular dementia.CC BY · PubMed Central
Figure 2: Multimodal AI neuroimaging framework for cognitive disorders. The current AI-powered framework integrates multimodal neuroimaging data [e.g. structural MRI (sMRI), functional MRI (fMRI), diffusion tensor imaging (DTI), positron emission tomography (PET), and electroencephalography (EEG) data], which are primarily used for the early detection of cognitive impairment, the differential diagnosis of dementia, the prediction of disease progression trajectories, and population risk stratification. By enabling full-spectrum intelligent diagnostics and therapeutics, this approach optimizes intervention systems for cognitive disorders.
Figure 2: Multimodal AI neuroimaging framework for cognitive disorders. The current AI-powered framework integrates multimodal neuroimaging data [e.g. structural MRI (sMRI), functional MRI (fMRI), diffusion tensor imaging (DTI), positron emission tomography (PET), and electroencephalography (EEG) data], which are primarily used for the early detection of cognitive impairment, the differential diagnosis of dementia, the prediction of disease progression trajectories, and population risk stratification. By enabling full-spectrum intelligent diagnostics and therapeutics, this approach optimizes intervention systems for cognitive disorders.CC BY · PubMed Central
Figure 3: Challenges and potential solutions of multimodal AI applications in cognitive disorder research.
Figure 3: Challenges and potential solutions of multimodal AI applications in cognitive disorder research.CC BY · PubMed Central

Verification

Claims the paper makes

90 Valid · 4 Not valid · 44 Not checked · 67 Own results and interpretations

112 more claims · 47 with their cited sources checked

Create a free account to see all 205 claims and to verify the 7 references still open.

See all claims — free account
  • It may state two separate claims as one. 73
  • Probably not a substantial claim. 21
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Cited by

See all 10

Metadata

Authors
Dang, M., Liu, B., Chen, Y., & Zhang, Z.
Affiliations
Beijing Normal University (CN)
Corresponding author
  • Chen, Yaojing
  • Zhang, Zhanjun
Venue
Psychoradiology
Published
2026
Volume
6
Pages
kkag007-kkag007
ISSN
2634-4416 (ISSN-L)
OpenAlex
W7135047425
Cited by
10
References
169
Citations by year
2026: 10
FWCI
10.02
Type
journal article
Language
en
Open access
Locations
  • Psychoradiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Science and Technology Innovation 2030 Major Projects (2022ZD0211600)
  • National Key Research and Development Program of China (2023YFC3605400)
  • China Postdoctoral Science Foundation (GZC20252268)
  • Beijing Nova Program
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
cognitive disorders, dementia, multimodal neuroimaging, artificial intelligence, precision medicine, multimodal fusion, explainable AI, artificial neural networks, presymptomatic biomarkers, differential diagnosis, disease progression prediction, patient stratification, federated learning, demographic bias, non-Alzheimer's dementia, neurodegenerative diseases, missing modalities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.